101 related articles for article (PubMed ID: 12377602)
1. Dynamic changes of matrix metalloproteinases in rat liver during the development of diethylnitrosamine-induced hepatocarcinoma.
Gao Y; Zhang Z; Jiang ZS; Fang SG; Sun EW; Wang Y; Chen BH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):865-8. PubMed ID: 12377602
[TBL] [Abstract][Full Text] [Related]
2. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Sivaramakrishnan V; Niranjali Devaraj S
Chem Biol Interact; 2009 Aug; 180(3):353-9. PubMed ID: 19539802
[TBL] [Abstract][Full Text] [Related]
3. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
4. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
5. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9.
Liu YN; Pan SL; Peng CY; Guh JH; Huang DM; Chang YL; Lin CH; Pai HC; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2006 Jan; 316(1):35-41. PubMed ID: 16183705
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
Volman TJ; Goris RJ; Lomme RM; DeGroot J; Verhofstad AA; Hendriks T
J Pathol; 2004 Aug; 203(4):968-75. PubMed ID: 15259001
[TBL] [Abstract][Full Text] [Related]
7. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
8. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
11. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
12. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
13. [Differences between the expression of matrix metalloproteinase-2, 9 in preeclampsia and normal placental tissues].
Li JK; Xiong Q; Zhou S; Yang PF
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):73-5. PubMed ID: 17442176
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis].
Zhu YK; Wang BE; Shen FJ; Jia JD; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):509-12. PubMed ID: 16042886
[TBL] [Abstract][Full Text] [Related]
15. Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis.
Kurakata H; Oka M; Matsubara Y; Niwa T; Utsunomiya H; Fujishiro M; Miki K; Fukamachi H; Kubota S; Ichinose M
Dev Growth Differ; 2008 Jan; 50(1):41-8. PubMed ID: 17986262
[TBL] [Abstract][Full Text] [Related]
16. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Krüger A; Soeltl R; Sopov I; Kopitz C; Arlt M; Magdolen V; Harbeck N; Gänsbacher B; Schmitt M
Cancer Res; 2001 Feb; 61(4):1272-5. PubMed ID: 11245418
[TBL] [Abstract][Full Text] [Related]
17. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
18. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
Zhang H; Lin QD; Qiao C
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
[TBL] [Abstract][Full Text] [Related]
19. [Matrix metalloproteinases map of lymphogenous metastasis of hepatocarcinoma cell in mice].
Cui XN; Hou L; Liu JW; Ling MY
Ai Zheng; 2002 Nov; 21(11):1192-6. PubMed ID: 12526214
[TBL] [Abstract][Full Text] [Related]
20. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
Kuroda T; Yoshida Y; Kamiie J; Kovalenko P; Nameta M; Fujinaka H; Yaoita E; Endo T; Ishizuka S; Nakabayashi K; Yamada A; Nagasawa T; Yamamoto T
Clin Exp Nephrol; 2004 Sep; 8(3):206-15. PubMed ID: 15480897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
